This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Sept. 16, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, today announced plans to release fourth quarter ended
June 30, 2011 financial results on
Tuesday, September 20, 2011. Michael A. McManus, President and Chief Executive Officer and
Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at
4:30 p.m. Eastern on
Tuesday, September 20, 2011 to discuss the Company's fourth quarter 2011 financial results.
Shareholders and other interested parties may participate in the conference call by dialing 866.713.8567 (domestic) or 617.597.5326 (international) and entering access code 17485827, a few minutes before the start of the call. A simultaneous webcast will be available via Misonix's website at
www.misonix.com. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available approximately 2 hours after the event through
September 27, 2011. The dial-in number to listen to the recording is (888) 286-8010 or (617) 801-6888. The replay access code is 72872107.
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of
$3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at
Investor Relations Contact:
Kevin M. McGrathCameron Associates, Inc.212 245 4577
SOURCE Misonix, Inc.